🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Seli Sikiilii › Distaarikii Koloombiyaa

Qorannoo klinikaalii Dhibee Seli Sikiilii Distaarikii Koloombiyaa keessatti

Qorannoo 10 Dhibee Seli Sikiilii f Distaarikii Koloombiyaa keessatti hirmaatuu jiru.

Magaalota Distaarikii Koloombiyaa keessatti

Takkalaa qorannoo (Ingiliffa)

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • Childrens National Hospital, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06439082

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • Childrens National Medical Ctr, Washington D.C.
  • MedStar Hlth Res Institute, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06612268

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Georgetown University, Washington D.C.
  • Children's National Hemophilia Center, Washington D.C.
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT04398628

Cooperative Assessment of Late Effects for SCD Curative Therapies

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 4 hanga 65 · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT05153967

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Children's National Hospital (MRD-HCT), Washington D.C.
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 3 hanga 20 · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT06941389

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

  • Children's National Hospital, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 4 hanga 21 · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT06635902

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

  • Children's National Health System, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 hanga 25 · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT03587272

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

  • Children's National Hospital, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 hanga 25 · Saalaa hunda · Haaromfame 26-Ful-2025 · NCT06358638

Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease

  • Children's National Hospital, Washington D.C.
Namoota walitti qabaa jira
Umuriin 7 hanga 16 · Saalaa hunda · Haaromfame 13-Gur-2025 · NCT06770010

Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease

  • Children's National Hospital, Washington D.C.
Namoota walitti qabaa jira
Umuriin 8 hanga 16 · Saalaa hunda · Haaromfame 10-Ama-2025 · NCT05099874

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.